comprehensive -WSS

comprehensive

author：fashion 2025-09-28 22:52:47 - browse：42

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： The Readout: Gilead, Bernie Sanders, and other pharma news

WSS

Medicare Advantage proposed rates disappoint insurers

Why did Pfizer dish out millions for a Super Bowl ad?

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Key House Republican on health care plans exit from Congress

Latigo launches with $135 million for Vertex

Resistance to opioid

hotspot

comprehensive

hotspot

Virginia high school admissions case could be legal follow

Latigo launches with $135 million for Vertex

Trump demands the U.S. pay no more for drugs than other countries … again

Key House Republican on health care plans exit from Congress

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Heart attack and stroke risk calculators need revising

A disappointing year of Humira biosimilars

Anesthesiologist group: stop taking Ozempic before surgery

Eli Lilly reports tirzepatide MASH success during Q4 earnings

hotspot

BioAge raises $170M for combination therapy with Zepbound

Vaccine advisory panel ACIP left half staffed by HHS

Biden report: The neurospychology of memory and aging

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Readout Newsletter: Amylyx, Aurinia, and IQVIA

AMAs digital advisors table RPM coding reform proposal, again

focus

knowledge

entertainment

explore